Trinity Capital Inc. Provides $20 Million in Growth Capital to Emboline, Inc. to Advance Interventional Heart Procedure Technology

Trinity Capital Inc. Provides $20 Million in Growth Capital to Emboline, Inc. to Advance Interventional Heart Procedure Technology Accessibility Statement Skip NavigationPHOENIX, March 11, 2026 /PRNewswire/ -- Trinity Capital Inc.(Nasdaq: TRIN) ("Trinity"), a leading international alternative asset manager, today announced the commitment of $20 million in growth capital to Emboline, Inc.("Emboline"), a MedTech company focused on reducing strokes and other complications during interventional heart procedures ...